Details
Home
Trade Portal
Customs
Licensing
Sanitary and Phytosanitary & Veterinary regulation
Technical requirements
BCC/CCP police control
Trade regime
Public Procurement
SPS Database
Search SPS Database
Reports
Laboratories
Memberships of international organizations
Food and feed producers / Importers / Warehouses
Food export Establishment
Agricultural support
Certificates in use
Bilateral and International Agreements
Customs tariffs
TBT Platform
Search TBT Database
Quality Infrastructure
Accreditation
Standardization
Conformity Assessment
Metrology
Market Surveillance
MABD
Reports
BTI Database
Services Regulatory
Database
Measures in Services
Notifications
Statistical Portal
Trade in Goods
Trade in Services
Foreign Direct Investment
Foreign Affiliates Trade Statistics
Raw Data Export
Indicators
Macroeconomic Data
Reports
Market surveillance
Product safety
Administrative institutions
Authorized Economic Operator
Recognized AEOs
Login
Back
Previous Record
Next Record
Issuing CEFTA Economy
Serbia
BTI Reference
1925/17
Validity Start Date
16/03/2017
Validity End Date
16/03/2020
Nomenclature code
3002150000
Justification
Language
Српски језик
Issuing place
Beograd
Issuing date
Goods description
Imunološki proizvod (lek), pripremljen u pakovanju za prodaju na malo. Predmetna roba je u vidu praha, upakovanog u staklenu bocicu, koja se uz uputstvo za upotrebu isporucuje u kartonskoj kutiji sa naštampanom proizvodackom deklaracijom. Proizvod sadrži vedolizumab (monoklonsko antitelo) 300 mg, kao aktivnu komponentu, i pomocne supstance: L-histidin, L-histidin hidrohlorid, L-arginin hidrohlorid, saharozu i polisorbat 80. Nakon rekonstitucije, 1 ml rastvora sadrži 60 mg vedolizumaba. Primenjuje se putem intravenske infuzije, nakon rekonstitucije dodatkom vode za injekcije, u lecenju Kronove bolesti i ulceroznog kolitisa, kod odraslih kod kojih nije postignut zadovoljavajuci odgovor, ili je odgovor postao neadekvatan, bilo na standardnu terapiju ili na antagoniste faktora nekroze tumora alfa (TNFa), kao i kod onih koji takvu terapiju nisu podnosili.
National keywords
imunološki proizvod
Uploaded Documents
Export to PDF
×